Catherine Pearce

This profile gathers the share dealings of Catherine Pearce in CinCor Pharma, Inc., where the filings describe the role as senior executive. We count 4 filings; the first trade dates from 11 January 2022 and the latest from 24 February 2023.

The open-market record is one-sided, with 1 purchase worth €11k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 1 option exercise.

On 24 February 2023 came the latest disclosure, a transaction in CinCor Pharma, Inc. The clock since the last published purchase (13 January 2022) now reads 1,739 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.